Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Data from EBV-upregulated B7-H3 inhibits NK cell–mediated antitumor function and contributes to nasopharyngeal carcinoma progression
  1. Home
  2. Publications
  3. Supplementary Data from EBV-upregulated B7-H3 inhibits NK cell–mediated antitumor function and contributes to nasopharyngeal carcinoma progression

Supplementary Data from EBV-upregulated B7-H3 inhibits NK cell–mediated antitumor function and contributes to nasopharyngeal carcinoma progression

Authors:
  • HCHaiwen Chen
    Haiwen Chen
  • XDXiaobing Duan
    Xiaobing Duan
  • XDXiaohong Deng
    Xiaohong Deng
  • YHYingping Huang
    Yingping Huang
  • XZXiang Zhou
    Xiang Zhou
  • SZShanshan Zhang
    Shanshan Zhang
  • XZXiao Zhang
    Xiao Zhang
  • PLPingjuan Liu
    Pingjuan Liu
  • CYChaopin Yang
    Chaopin Yang
  • GLGuojun Liu
    Guojun Liu
  • QRQinqin Ren
    Qinqin Ren
  • YXYan Xiong
    Yan Xiong

Open Access
Publisher website
Google Scholar
  • 16 September 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.27026399
Abstract
Supplementary Figures and Tables
Keywords
  • HEAD, NECK & ORAL CANCERS
  • IMMUNOLOGY
  • NK CELLS
  • IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.